US 10543257
Lentiviral vector for treating hemoglobin disorders
granted A61KA61K38/42A61K48/005
Quick answer
US patent 10543257 (Lentiviral vector for treating hemoglobin disorders) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K38/42, A61K48/005